• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction: The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.

作者信息

Al Sulaiman Khalid, Aljuhani Ohoud, Badreldin Hisham A, Korayem Ghazwa B, Alenazi Abeer A, Alharbi Ahlam H, Alghamdi Albandari, Alhubaishi Alaa, Altebainawi Ali F, Bosaeed Mohammad, Alotaibi Rand, Alawad Ahad, Alnajjar Nirvana, Saleh Khalid Bin, Sait Walaa A, Alsohimi Samiah, Alanizy Meshari M, Almuqbil Sarah A, Al Sulaihim Ibrahim, Vishwakarma Ramesh, Alalawi Mai, Alhassan Fatimah, Alghnam Suliman

机构信息

Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)-Ministry of National Guard Health Afairs (MNGHA), Riyadh, Saudi Arabia.

College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, P.O. Box 22490, Riyadh, 11426, Saudi Arabia.

出版信息

BMC Infect Dis. 2023 Feb 22;23(1):103. doi: 10.1186/s12879-023-08072-8.

DOI:10.1186/s12879-023-08072-8
PMID:36814218
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9944396/
Abstract
摘要

相似文献

1
Correction: The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.更正：新型冠状病毒肺炎危重症患者合并其他呼吸道病毒感染的临床结局：一项多中心队列研究。
BMC Infect Dis. 2023 Feb 22;23(1):103. doi: 10.1186/s12879-023-08072-8.
2
The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.COVID-19 危重症患者合并其他呼吸道病毒感染的临床结局：一项多中心队列研究。
BMC Infect Dis. 2023 Feb 6;23(1):75. doi: 10.1186/s12879-023-08010-8.
3
Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.评价吸入一氧化氮（iNO）治疗 COVID-19 重症危重症患者中中重度急性呼吸窘迫综合征（ARDS）的效果：一项多中心队列研究。
Crit Care. 2022 Oct 3;26(1):304. doi: 10.1186/s13054-022-04158-y.
4
Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19.新冠肺炎危重症患者新发心房颤动的发生率及临床转归：一项多中心队列研究——新发心房颤动与 COVID-19。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231156178. doi: 10.1177/10760296231156178.
5
Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study.中国新型冠状病毒传染病（COVID-19）危重症患者的临床特征和结局：一项回顾性多中心研究。
Intensive Care Med. 2020 Oct;46(10):1863-1872. doi: 10.1007/s00134-020-06211-2. Epub 2020 Aug 20.
6
Comparison of Clinical Findings in SARS-CoV-2 with Other Respiratory Viruses in Critically Ill Children during the COVID-19 Pandemic.COVID-19 大流行期间危重症儿童中 SARS-CoV-2 与其他呼吸道病毒的临床特征比较。
J Trop Pediatr. 2021 Dec 8;67(6). doi: 10.1093/tropej/fmab102.
7
The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study.托珠单抗治疗 COVID-19 老年危重症患者的安全性和有效性：一项多中心队列研究。
Int J Infect Dis. 2022 Sep;122:252-259. doi: 10.1016/j.ijid.2022.05.038. Epub 2022 May 20.
8
Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.评价 COVID-19 重症患者低剂量阿司匹林的使用：一项多中心倾向评分匹配研究。
J Intensive Care Med. 2022 Sep;37(9):1238-1249. doi: 10.1177/08850666221093229. Epub 2022 Apr 21.
9
Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study.《2019 年冠状病毒病（COVID-19）危重症患者的临床特征和结局：一项多中心队列研究》
Int J Infect Dis. 2021 Apr;105:180-187. doi: 10.1016/j.ijid.2021.02.037. Epub 2021 Feb 15.
10
Pneumothorax in critically ill patients with COVID-19 infection: Incidence, clinical characteristics and outcomes in a case control multicenter study.COVID-19 感染危重症患者的气胸：一项病例对照多中心研究的发生率、临床特征和结局。
Respir Med. 2021 Aug;184:106464. doi: 10.1016/j.rmed.2021.106464. Epub 2021 May 13.

引用本文的文献

1
Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT).在 COVID-19 大流行期间的呼吸道病毒合并感染：2/3 期 molnupiravir 试验（MOVe-OUT）的流行病学分析和临床结局。
Microbiol Spectr. 2024 Mar 5;12(3):e0356323. doi: 10.1128/spectrum.03563-23. Epub 2024 Feb 1.
2
The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study.托珠单抗在 COVID-19 合并肾功能损害重症患者中的应用：一项多中心队列研究。
Ren Fail. 2023;45(2):2268213. doi: 10.1080/0886022X.2023.2268213. Epub 2023 Oct 23.

本文引用的文献

1
The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.COVID-19 危重症患者合并其他呼吸道病毒感染的临床结局：一项多中心队列研究。
BMC Infect Dis. 2023 Feb 6;23(1):75. doi: 10.1186/s12879-023-08010-8.